Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Copple

Showing results (41-50 of 48) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 48 results.
Free Radical Biology & Medicine|December 3, 2014
Brusatol provokes a rapid and transient inhibition of Nrf2 signaling and sensitizes mammalian cells to chemical toxicity-implications for therapeutic targeting of Nrf2Adedamola Olayanju, Ian M Copple, Holly K Bryan, et al.
Journal of the National Cancer Institute|December 1, 2025
NQO1 as a predictor of response to adjuvant GemCap treatment for pancreatic cancerDylan Williams, Chandni Patel, Kate Murray, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|August 30, 2023
A systems approach reveals species differences in hepatic stress response capacityGiusy Russomanno, Rowena Sison-Young, Lucia A Livoti, et al.
Nature Reviews. Drug Discovery|November 22, 2019
Managing the challenge of drug-induced liver injury: a roadmap for the development and deployment of preclinical predictive modelsRichard J Weaver, Eric A Blomme, Amy E Chadwick, et al.
Hepatology (Baltimore, Md.)|April 19, 2021
Pharmacological Activation of Nrf2 Enhances Functional Liver RegenerationBenjamin K Y Chan, Mohamed Elmasry, Shiva S Forootan, et al.
Journal of Hepatology|February 8, 2022
Interruption of bile acid uptake by hepatocytes after acetaminophen overdose ameliorates hepatotoxicityAhmed Ghallab, Reham Hassan, Ute Hofmann, et al.
Nature Reviews. Drug Discovery|October 28, 2025
Quantitative systems toxicology: modelling to mechanistically understand and predict drug safetyChristopher E Goldring, Giusy Russomanno, Carmen Pin, et al.
Nature Communications|May 25, 2017
A tetraoxane-based antimalarial drug candidate that overcomes PfK13-C580Y dependent artemisinin resistancePaul M O'Neill, Richard K Amewu, Susan A Charman, et al.
Pageof 5

Showing results (41-50 of 48) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
Free Radical Biology & Medicine|December 3, 2014
Brusatol provokes a rapid and transient inhibition of Nrf2 signaling and sensitizes mammalian cells to chemical toxicity-implications for therapeutic targeting of Nrf2Adedamola Olayanju, Ian M Copple, Holly K Bryan, et al.
Journal of the National Cancer Institute|December 1, 2025
NQO1 as a predictor of response to adjuvant GemCap treatment for pancreatic cancerDylan Williams, Chandni Patel, Kate Murray, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|August 30, 2023
A systems approach reveals species differences in hepatic stress response capacityGiusy Russomanno, Rowena Sison-Young, Lucia A Livoti, et al.
Nature Reviews. Drug Discovery|November 22, 2019
Managing the challenge of drug-induced liver injury: a roadmap for the development and deployment of preclinical predictive modelsRichard J Weaver, Eric A Blomme, Amy E Chadwick, et al.
Hepatology (Baltimore, Md.)|April 19, 2021
Pharmacological Activation of Nrf2 Enhances Functional Liver RegenerationBenjamin K Y Chan, Mohamed Elmasry, Shiva S Forootan, et al.
Journal of Hepatology|February 8, 2022
Interruption of bile acid uptake by hepatocytes after acetaminophen overdose ameliorates hepatotoxicityAhmed Ghallab, Reham Hassan, Ute Hofmann, et al.
Nature Reviews. Drug Discovery|October 28, 2025
Quantitative systems toxicology: modelling to mechanistically understand and predict drug safetyChristopher E Goldring, Giusy Russomanno, Carmen Pin, et al.
Nature Communications|May 25, 2017
A tetraoxane-based antimalarial drug candidate that overcomes PfK13-C580Y dependent artemisinin resistancePaul M O'Neill, Richard K Amewu, Susan A Charman, et al.
Pageof 5